Los Angeles Capital Management LLC Sutro Biopharma, Inc. Transaction History

Los Angeles Capital Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	BUY	$3.29 - $4.9 $38,822 - $57,820	11,800 Added 20.88%	68,324 $237,000
Q2 2023 Aug 03, 2023	BUY	$4.25 - $5.88 $45,347 - $62,739	10,670 Added 23.27%	56,524 $262,000
Q1 2023 May 04, 2023	SELL	$4.48 - $8.45 $77,369 - $145,931	-17,270 Reduced 27.36%	45,854 $211,000
Q4 2022 Feb 06, 2023	SELL	$5.41 - $8.08 $30,079 - $44,924	-5,560 Reduced 8.1%	63,124 $510,000
Q2 2022 Aug 05, 2022	BUY	$3.41 - $8.95 $94,388 - $247,735	27,680 Added 67.51%	68,684 $358,000
Q3 2021 Nov 08, 2021	SELL	$16.88 - $22.38 $46,420 - $61,545	-2,750 Reduced 6.29%	41,004 $775,000
Q2 2021 Aug 05, 2021	BUY	$18.03 - $23.82 $788,884 - $1.04 Million	43,754 New	43,754 $813,000
Q4 2020 Feb 04, 2021	SELL	$10.16 - $23.98 $301,152 - $710,791	-29,641 Closed	0 $0
Q3 2020 Nov 02, 2020	BUY	$7.44 - $13.15 $43,055 - $76,099	5,787 Added 24.26%	29,641 $298,000
Q2 2020 Aug 05, 2020	BUY	$7.24 - $11.05 $172,702 - $263,586	23,854 New	23,854 $185,000

136

62.4M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $131M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.